Search Results for: ATXN7

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CPOX coproporphyrinogen oxidase
  • Heme biosynthesis
  • Hepatic porphyria, including: Porphyria Cutanea Tarda (PCT); VHepatoerythropoietic porphyria; Acute Intermittent Porphyria (AIP); Variegate porphyria (VP); ALA-dehydratase deficiency porphyria (ALADP); Hereditary Coproporphyria (HCP)
Novel GNAT1 G protein subunit alpha transducin 1
  • PLC beta mediated events
  • PLC beta mediated events
  • G-protein activation
  • Activation of the phototransduction cascade
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G alpha (i) signalling events
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
  • Cacodylic acid
  • Guanosine-5'-Diphosphate
  • Tetrafluoroaluminate Ion
  • Congenital stationary night blindness (CSNB), including: CSNB type 1 (CSNB1); CSNB type 2 (CSNB2); CSNB autosomal dominant (CSNBAD); Oguchi disease/ CSNB Oguchi type (CSNBO)
Novel IMPDH2 inosine monophosphate dehydrogenase 2
  • Neutrophil degranulation
  • Purine ribonucleoside monophosphate biosynthesis
  • Potential therapeutics for SARS
  • NADH
  • Mycophenolate mofetil
  • Ribavirin
  • Mycophenolic acid
  • Mercaptopurine
  • Selenazole-4-carboxyamide-adenine dinucleotide
  • 6-Chloropurine Riboside, 5'-Monophosphate
  • Inosinic Acid
  • VX-148
Novel PDHB pyruvate dehydrogenase E1 subunit beta
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Glyoxylate metabolism and glycine degradation
  • Signaling by Retinoic Acid
  • Pyruvate metabolism
  • Pyruvic acid
  • NADH
  • Pyruvate dehydrogenase complex deficiency; X-linked Leigh syndrome
Novel SERINC3 serine incorporator 3
  • Serine biosynthesis
Novel SYNJ2 synaptojanin 2
  • Synthesis of PIPs at the plasma membrane
  • Clathrin-mediated endocytosis
ACTN1 actinin alpha 1
  • Platelet degranulation
  • Syndecan interactions
  • Nephrin family interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • Human calcitonin
  • Copper
ACTN2 actinin alpha 2
  • Platelet degranulation
  • Nephrin family interactions
  • Striated Muscle Contraction
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • RAF/MAP kinase cascade
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
ACTN4 actinin alpha 4
  • Platelet degranulation
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
ADAM33 ADAM metallopeptidase domain 33
  • Asthma
AGRN agrin
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • HS-GAG biosynthesis
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • Integrin cell surface interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective B3GAT3 causes JDSSDHD
  • Defective EXT2 causes exostoses 2
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • NCAM1 interactions
  • Defective B3GALT6 causes EDSP2 and SEMDJL1
  • Retinoid metabolism and transport
  • Congenital myasthenic syndrome
CARD10 caspase recruitment domain family member 10
CEP70 centrosomal protein 70
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
CEP72 centrosomal protein 72
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
COG6 component of oligomeric golgi complex 6
  • COPI-mediated anterograde transport
  • Intra-Golgi traffic
  • Retrograde transport at the Trans-Golgi-Network
CRIM1 cysteine rich transmembrane BMP regulator 1
CRX cone-rod homeobox
  • Leber congenital amaurosis (LCR)
  • Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
EFEMP1 EGF containing fibulin extracellular matrix protein 1
  • Molecules associated with elastic fibres
  • Molecules associated with elastic fibres
  • Familial flecked retina syndrome, including: Doyne honeycomb degeneration of retina (DHRD); Basal laminar drusen (BLD); Fundus albipunctatus (FA); Retinitis punctata albescens (RPA); Bietti crystalline corneoretinal dystrophy (BCD)
EFEMP2 EGF containing fibulin extracellular matrix protein 2
  • Molecules associated with elastic fibres
  • Molecules associated with elastic fibres
  • Cutis laxa, including: Autosomal dominant cutis laxa (ADCL); Autosomal recessive cutis laxa I (ARCL1); Autosomal recessive cutis laxa II (ARCL2); X-linked recessive cutis laxa (XRCL); Wrinkly skin syndrome
FBN1 fibrillin 1
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Elastic fibre formation
  • Molecules associated with elastic fibres
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Ectopia lentis
  • Shprintzen-Goldberg syndrome
  • MASS phenotype
  • Marfan syndrome, including: Marfan syndrome (MFS); Neonatal MFS; Atypically severe MFS; New variant of MFS
  • Weill-Marchesani syndrome, including: Weill-Marchesani syndrome; Weill-Marchesani-like syndrome
  • Geleophysic dysplasia

Page 1 out of 4 pages